Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

CUSIP: 877619106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
285,714,286
Total 13F shares
17,661,042
Share change
-337,509
Total reported value
$358,518,075
Price per share
$20.30
Number of holders
46
Value change
-$11,587,017
Number of buys
20
Number of sells
22

Security key

877619106

Report period

Q1 2021

Institutions

46

Top holders

10

Top shareholders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
2%
5,664,215
$147,862,000 31 Dec 2020
13F
BlackRock Finance, Inc.
13F
Company
0.78%
2,229,816
$59,181,000 31 Dec 2020
13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
13F
Company
0.7%
2,000,000
$53,080,000 31 Dec 2020
13F
Artal Group S.A.
13F
Company
0.36%
1,040,882
$27,625,000 31 Dec 2020
13F
Casdin Capital, LLC
13F
Company
0.29%
820,440
$21,774,000 31 Dec 2020
13F
SANDS CAPITAL MANAGEMENT, LLC
13F
Company
0.29%
820,440
$21,774,000 31 Dec 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.28%
799,529
$21,220,000 31 Dec 2020
13F
Alphabet Inc.
13F
Company
0.22%
640,882
$17,009,000 31 Dec 2020
13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
0.17%
500,000
$13,270,000 31 Dec 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.16%
470,440
$12,485,000 31 Dec 2020
13F
VANGUARD GROUP INC
13F
Company
0.16%
464,850
$12,337,000 31 Dec 2020
13F
TimesSquare Capital Management, LLC
13F
Company
0.15%
424,400
$11,264,000 31 Dec 2020
13F
Avidity Partners Management LP
13F
Company
0.14%
392,000
$10,404,000 31 Dec 2020
13F
Octagon Capital Advisors LP
13F
Company
0.11%
320,440
$8,504,000 31 Dec 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.09%
250,000
$6,635,000 31 Dec 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
163,814
$4,347,000 31 Dec 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.04%
128,174
$3,402,000 31 Dec 2020
13F
STATE STREET CORP
13F
Company
0.04%
110,106
$2,922,000 31 Dec 2020
13F
VR Adviser, LLC
13F
Company
0.04%
107,982
$2,866,000 31 Dec 2020
13F
NORTHERN TRUST CORP
13F
Company
0.04%
103,258
$2,740,000 31 Dec 2020
13F
Nantahala Capital Management, LLC
13F
Company
0.03%
78,576
$2,085,000 31 Dec 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
52,232
$1,387,000 31 Dec 2020
13F
Alyeska Investment Group, L.P.
13F
Company
0.02%
50,000
$1,327,000 31 Dec 2020
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.01%
41,003
$1,088,000 31 Dec 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.01%
35,752
$949,000 31 Dec 2020
13F
UBS Group AG
13F
Company
0.01%
35,749
$949,000 31 Dec 2020
13F
MORGAN STANLEY
13F
Company
0.01%
31,338
$832,000 31 Dec 2020
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.01%
30,000
$796,000 31 Dec 2020
13F
Bank of New York Mellon Corp
13F
Company
0.01%
26,980
$716,000 31 Dec 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
23,748
$630,000 31 Dec 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.01%
19,400
$515,000 31 Dec 2020
13F
CHARTWELL INVESTMENT PARTNERS, LLC
13F
Company
0.01%
18,737
$497,000 31 Dec 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
14,763
$392,000 31 Dec 2020
13F
Nuveen Asset Management, LLC
13F
Company
0%
14,228
$378,000 31 Dec 2020
13F
Point72 Asset Management, L.P.
13F
Company
0%
13,366
$355,000 31 Dec 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0%
13,128
$348,000 31 Dec 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
12,441
$330,000 31 Dec 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
6,556
$174,000 31 Dec 2020
13F
DEUTSCHE BANK AG\
13F
Company
0%
6,089
$162,000 31 Dec 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0%
5,045
$134,000 31 Dec 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0%
4,900
$130,000 31 Dec 2020
13F
Cubist Systematic Strategies, LLC
13F
Company
0%
4,453
$118,000 31 Dec 2020
13F
STRS OHIO
13F
Company
0%
2,100
$55,000 31 Dec 2020
13F
CITIGROUP INC
13F
Company
0%
1,614
$43,000 31 Dec 2020
13F
BANK OF MONTREAL /CAN/
13F
Company
0%
1,364
$38,000 31 Dec 2020
13F
Legal & General Group Plc
13F
Company
0%
914
$24,000 31 Dec 2020
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
727
$19,000 31 Dec 2020
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0%
720
$19,000 31 Dec 2020
13F
ROYAL BANK OF CANADA
13F
Company
0%
469
$12,000 31 Dec 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
293
$8,000 31 Dec 2020
13F

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q1 2021

As of 31 Mar 2021, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,661,042 shares. The largest 10 holders included FMR LLC, BlackRock Inc., UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, FRANKLIN RESOURCES INC, Artal Group S.A., Casdin Capital, LLC, SANDS CAPITAL MANAGEMENT, LLC, Alphabet Inc., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and PERCEPTIVE ADVISORS LLC. This page lists 46 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
51
Q1 2021 holders
46
Holder diff
-5
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .